NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE181541 Query DataSets for GSE181541
Status Public on Nov 30, 2021
Title MicroRNA profiling of Gingival tissue from chronically SIV infected rhesus macaques
Platform organism Homo sapiens
Sample organism Macaca mulatta
Experiment type Expression profiling by RT-PCR
Summary The study describes miRNA expression in Gingival tissue of chronically SIV-infected rhesus macaques. HIV/SIV-associated periodontal disease (gingivitis/periodontitis) (PD) represents a major comorbidity affecting HIV patients on anti-retroviral therapy. Employing a systems biology approach, we report molecular changes underlying PD and its modulation by phytocannabinoids [delta-9-tetrahydrocannabinol (9-THC)] in uninfected and SIV-infected rhesus macaques (RMs) untreated (VEH-untreated/SIV) or treated with vehicle (VEH/SIV) or 9-THC (THC/SIV). VEH- untreated/SIV but not THC/SIV RMs showed significant enrichment of genes linked to anti-viral defense, interferon-beta, NFkB, RIG-1, and JAK-STAT signaling. We focused on the anti-microbial DUOX1 and immune activation marker IDO1 that were reciprocally regulated in gingiva of VEH-untreated/SIV RMs. Both proteins localized to the gingival epithelium and CD163+ macrophages, and showed differential expression in the gingiva of THC/SIV and VEH/SIV RMs. Additionally, inflammation-associated miR-21, miR-142-3p, miR-223, and miR-125a-5p showed significantly higher expression in the gingiva of VEH/SIV RMs. In human primary gingival epithelial cells, miR-125a-5p post-transcriptionally downregulated DUOX1 These findings strongly support a role for differential miRNA expression associated with HIV/SIV induced gingival mucosal dysfunction.
 
Overall design Thirteen age and weight matched male Indian rhesus macaques were randomly divided into 3 groups. Group 1 (n=4) remained uninfected. Group 2 (VEH/SIV, n=6) animals were infected intravenously with 100TCID50 of SIVmac251. Group 3 (THC/SIV, n=3) were treated with delta-9-tetrahydrocannabinol and infected intravenously with 100TCID50 SIVmac251. Gingival tissue was collected at necropsy, ~180 days post SIV infection. ~100 ng of total RNA was first reverse transcribed and preamplified according to the manufacturer’s recommendation. MicroRNA expression profiling was performed using TaqMan ®OpenArray® Human microRNA panels. Data analysis was performed using ExpressionSuite® software, which utilizes the comparative Cτ (ΔΔCτ) method to rapidly and accurately quantify relative miRNA expression across many genes and samples. miRNA expression data were normalized using global normalization method. Comparisons were made between uninfected and VEH/SIV and THC/SIV and VEH/SIV rhesus macaques.
 
Contributor(s) Mohan M
Citation(s) 34954656
Submission date Aug 05, 2021
Last update date Jan 11, 2022
Contact name Mahesh Mohan
E-mail(s) mmohan@txbiomed.org
Organization name Southwest National Primate Research Center
Department Host Pathogen Interaction Program
Lab 12/106
Street address 8715 West Military Road
City San Antonio
State/province Texas
ZIP/Postal code 78227
Country USA
 
Platforms (1)
GPL17837 TaqMan OpenArray Human MicroRNA Panel (4461104)
Samples (13)
GSM5505090 IG78 Uninfected Controls
GSM5505091 II28 Uninfected Controls
GSM5505092 JB61 Uninfected Controls
Relations
BioProject PRJNA752386

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE181541_fold-change.txt.gz 10.1 Kb (ftp)(http) TXT
GSE181541_matrix_normalized_template.xls.gz 121.2 Kb (ftp)(http) XLS
GSE181541_non-normalized.txt.gz 26.1 Kb (ftp)(http) TXT
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap